Skip to main content
Premium Trial:

Request an Annual Quote

Nanosphere Targets $23.4M in Public Offering

NEW YORK (GenomeWeb News) – Nanosphere today said that it plans to offer 10.5 million shares of its common stock at $2.40 per share in a public offering.

The offering is expected to bring in net proceeds of about $23.4 million. It has granted its underwriters a 30-day option to purchase up to 1.575 million additional shares of common stock to cover any overallotments. If the option is exercised, net proceeds are expected to be about $26.9 million.

The offering is expected to close on July 24.

The Northbrook, Ill.-based molecular diagnostics firm said it intends to use net proceeds from the offering for general corporate purposes and working capital.

The offering is being made is being made pursuant to a shelf registration Nanosphere made on Sept. 15, 2009 to offer from time to time up to $100 million in any combination of common stock, warrants, preferred stock, stock purchase contracts and stock purchase units. Nanosphere today also filed a document with the US Securities and Exchange Commission to register and additional $5.5 million to the shelf registration.

Piper Jaffray is the sole book-running manager for the offering and Roth Capital Partners in the co-manager.

Shares of Quest were down 4 percent at $60.42 in Thursday morning trading on the Nasdaq.

On Monday, Nanospere reported preliminary second-quarter revenues of $1.3 million. It had cash and equivalents of $23.7 million as of June 30, 2012.

Nanosphere recently received de novo clearance from the US Food and Drug Administration to market its Gram-Positive Blood Culture Nucleic Acid Test (BC-GP) on its Verigene System.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.